Automated Telephone Reminder for Colonoscopy

February 14, 2017 updated by: Dr. Lawrence Hookey, Queen's University

Automated Telephone Reminder Prior to Outpatient Colonoscopy and the Effect on Bowel Preparation Quality

This is a quality improvement study to determine the impact of an automated telephone reminder on the quality of bowel preparation in patients undergoing outpatient colonoscopy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Randomized trial of automated reminders with bowel prep instructions and encouraging clear fluid ingestion. The phone calls will occur 48-96 hours prior to the scheduled colonoscopy.

All patients undergoing outpatient colonoscopy and prescribed sodium picosulfate plus magnesium citrate will be eligible for enrollment.

Study Type

Interventional

Enrollment (Actual)

234

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Ontario
      • Kingston, Ontario, Canada, K7L5G2
        • Hotel Dieu Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients
  • Scheduled for outpatient colonoscopy at a later date
  • Prescribed evening-before or split-dose low volume preparation regimens

Exclusion Criteria:

  • Refusal to receive automated telephone reminder
  • No access to telephone
  • Urgent/emergent indication for colonoscopy
  • Prescribed a bowel prep other than Pico-Salax/Purgodan
  • Receiving upper and lower combined procedure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Receiving reminder phone call
Will receive phone call to remind colonoscopy date and bowel prep
Other: Phone call
Automated phone call reminder
No Intervention: Not receiving reminder phone call
Will not receive phone call to remind colonoscopy date and bowel prep

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ottawa preparation scale score
Time Frame: Immediately after procedure
measures the cleanliness of each part of the colon and the overall fluid volume as assessed by the endoscopist
Immediately after procedure

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of glasses of fluid consumed pre-colonoscopy
Time Frame: 24 hours
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Queen's University

Investigators

  • Study Director: Matthew Church, Queen's University
  • Study Director: Natalie Rubinger, Queen's University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2015

Primary Completion (Actual)

May 15, 2016

Study Completion (Actual)

May 15, 2016

Study Registration Dates

First Submitted

June 18, 2015

First Submitted That Met QC Criteria

June 22, 2015

First Posted (Estimate)

June 23, 2015

Study Record Updates

Last Update Posted (Actual)

February 16, 2017

Last Update Submitted That Met QC Criteria

February 14, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 6013364

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Polyps

Clinical Trials on Phone call

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe